Brian Corvese - Agenus Independent Director
| AJ81 Stock | EUR 7.80 0.00 0.00% |
Director
Mr. Brian Corvese is an Independent Director of Agenus Inc. Since 1999, Mr. Corvese was the President and Founder of Vencor Capital, a private equity firm with telecommunications and technology investments in the Middle East and Mediterranean regions. Prior to working at Vencor, Mr. Corvese worked on investments in the U.S. and global equity markets as a Managing Director and partner at Soros Fund Management, the largest hedge fund in the world at the time. From 1988 to 1996, Mr. Corvese was a partner at Chancellor Capital Management, a 25 billion money management firm. While at Chancellor, Mr. Corvese was a Portfolio Manager with responsibility for investments made in basic industries, restructurings, and special situations, corporate governance investments, as well as founded and managed his own hedge fund. From 1981 to 1988, Mr. Corvese was with Drexel Burnham Lambert as an equity analyst following the chemical and specialty chemical industries and participated in a significant number of merger and acquisition activities. While at Drexel Mr. Corvese was a member of the top chemical and specialty chemical research team, as ranked by Institutional Investor. Mr. Corvese currently serves on the Board of Directors of the National Telecommunications Corporationrationration, based in Cairo, Egypt since 2007.
| Age | 60 |
| Tenure | 17 years |
| Phone | 781 674 4400 |
| Web | https://www.agenusbio.com |
Agenus Management Efficiency
The company has return on total asset (ROA) of (0.2577) % which means that it has lost $0.2577 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (18.903) %, meaning that it generated substantial loss on money invested by shareholders. Agenus' management efficiency ratios could be used to measure how well Agenus manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Robert Engbloom | Superior Plus Corp | 64 | |
| James Arestia | NorAm Drilling AS | N/A | |
| Laura Walker | NorAm Drilling AS | 60 | |
| Peter Murphy | NorAm Drilling AS | 55 | |
| Walentin Mirosh | Superior Plus Corp | 71 | |
| Richard Bradeen | Superior Plus Corp | 61 | |
| Douglas Harrison | Superior Plus Corp | 58 | |
| Ross Levinsohn | NorAm Drilling AS | 54 | |
| David Smith | Superior Plus Corp | 59 | |
| Michael Kreger | NorAm Drilling AS | 33 | |
| Peter Kern | NorAm Drilling AS | 50 | |
| Craig Jacobson | NorAm Drilling AS | 65 | |
| Catherine Best | Superior Plus Corp | 64 | |
| Mary Jordan | Superior Plus Corp | 58 | |
| Randall Findlay | Superior Plus Corp | 67 | |
| Eugene Bissell | Superior Plus Corp | 64 | |
| Patrick Gottschalk | Superior Plus Corp | 54 | |
Management Performance
| Return On Equity | -18.9 | |||
| Return On Asset | -0.26 |
Agenus Inc Leadership Team
Elected by the shareholders, the Agenus' board of directors comprises two types of representatives: Agenus inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Agenus. The board's role is to monitor Agenus' management team and ensure that shareholders' interests are well served. Agenus' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Agenus' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Robert Stein, Chief Scientific Officer | ||
| James Gorman, Vice President - Strategic Planning and Portfolio Management | ||
| Ozer Baysal, Chief Business Officer | ||
| Regina Grebla, VP Communications | ||
| Shalini Sharp, Director | ||
| John Castle, Head Bioinformatics | ||
| Wadih Jordan, Independent Director | ||
| Christine Klaskin, Principal Financial Officer, Principal Accounting Officer, Vice President - Finance | ||
| Jennifer Buell, Pres Therapeutics | ||
| Don Vidic, Vice President Head of Commercial | ||
| Brian Corvese, Independent Director | ||
| Karen Valentine, Vice President Chief Compliance Officer, General Counsel, Secretary | ||
| Evan Ballantyne, CFO | ||
| Timothy Wright, Lead Independent Director | ||
| Christian Cortis, Chief Strategy Officer and Head of Finance | ||
| Julie DeSander, Chief Officer | ||
| Ulf Wiinberg, Director | ||
| Alexander Duncan, CTO and Head - Research | ||
| Tracy Clemente, Chief Officer | ||
| Allison JeynesEllis, Director | ||
| Garo Armen, Chairman of the Board, CEO | ||
| JeanMarie Cuillerot, Chief Medical Officer | ||
| Andrea Rabney, IR Contact Officer | ||
| Craig Winter, Chief Officer | ||
| Robin JD, Chief Officer | ||
| Shahzad Malik, Independent Director | ||
| Evan Kearns, Vice President General Counsel, Secretary |
Agenus Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Agenus a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -18.9 | |||
| Return On Asset | -0.26 | |||
| Profit Margin | (2.39) % | |||
| Operating Margin | (1.99) % | |||
| Current Valuation | 646 M | |||
| Shares Outstanding | 304.81 M | |||
| Shares Owned By Insiders | 8.96 % | |||
| Shares Owned By Institutions | 65.26 % | |||
| Price To Earning | (3.13) X | |||
| Price To Book | 181.30 X |
Pair Trading with Agenus
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Agenus position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agenus will appreciate offsetting losses from the drop in the long position's value.Moving against Agenus Stock
| 0.71 | TM2 | Sydbank A/S | PairCorr |
| 0.7 | 0QF | Moderna | PairCorr |
| 0.67 | BFP | BBVA Banco Frances | PairCorr |
| 0.65 | SON1 | Sony Group Corp | PairCorr |
| 0.58 | MIZ | Mizuno | PairCorr |
The ability to find closely correlated positions to Agenus could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Agenus when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Agenus - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Agenus Inc to buy it.
The correlation of Agenus is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Agenus moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Agenus Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Agenus can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Agenus Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. Note that the Agenus Inc information on this page should be used as a complementary analysis to other Agenus' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Complementary Tools for Agenus Stock analysis
When running Agenus' price analysis, check to measure Agenus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Agenus is operating at the current time. Most of Agenus' value examination focuses on studying past and present price action to predict the probability of Agenus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Agenus' price. Additionally, you may evaluate how the addition of Agenus to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |